Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity-Reference-Cited by-同舟云学术

Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity

Published:2018-05 Issue:20 Volume:71 Page:2281-2290
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Avila Mônica Samuel,Ayub-Ferreira Silvia Moreira,de Barros Wanderley Mauro Rogerio,das Dores Cruz Fatima,Gonçalves Brandão Sara Michelly,Rigaud Vagner Oliveira Carvalho,Higuchi-dos-Santos Marília Harumi,Hajjar Ludhmila Abrahão,Kalil Filho Roberto,Hoff Paulo Marcelo,Sahade Marina,Ferrari Marcela S.M.,de Paula Costa Romulo Leopoldo,Mano Max Senna,Bittencourt Viana Cruz Cecilia Beatriz,Abduch Maria Cristina,Lofrano Alves Marco Stephan,Guimaraes Guilherme Veiga,Issa Victor Sarli,Bittencourt Marcio Sommer,Bocchi Edimar Alcides

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging;Bloom;Circ Heart Fail,2016

2. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study;Patnaik;Breast Cancer Res,2011

3. Cardiotoxicity of anticancer treatments;Ewer;Nat Rev Cardiol,2015

4. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin,2016

5. Cancer drugs and the heart: importance and management;Suter;Eur Heart J,2013

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers;Current Problems in Cardiology;2024-03

2. Doxorubicin-induced cardiotoxicity and risk factors;IJC Heart & Vasculature;2024-02

3. A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging;npj Aging;2024-01-23

4. Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction;JACC: CardioOncology;2024-01

5. Prophylaxis to Prevent Cardiotoxicity in Patients Receiving Anthracycline for Breast Cancer: A Combined Bayesian and Frequentist Network Meta-Analysis of Randomised Controlled Trials;Heart, Lung and Circulation;2024-01